|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Toxicology and pharmacokinetics of intravesical gemcitabine: a preclinical study in dogs显示文摘 | Bajorin DF Tong W | 1999 | Clin Cancer Res1999，5，9： | 1 |
| 2 | Neoadjuvant chemotherapy and bldder sparing surgery for invasive bladder cancer:ten year outcome显示文摘 | Herr HW Bajorin DF Scher HI | | 0，，： | 1 |
| 3 | Longterm survival in metastatic transitionalcell carcinoma and prognostic factors predicting outcome of therapy显示文摘 | BAJORIN DF DODD PM MAZUMDAR M | 1999 | Clin Oncol1999，17，10： | 1 |
| 4 | Etoposide plus carboplatin or cisplatin in good-risk patients with germ cell tumors:a randomized comparison显示文摘 | Bosl GJ Bajorin DF | 1994 | Semin Oncol1994，21，512： | 1 |
| 5 | Chemotherapy for teratoma with malignant transformation显示文摘 | Donadio AC Motzer RJ Bajorin DF | 2003 | J Clin Oncol2003，21，： | 1 |
| 6 | Clinical cancer advances 2005: major research advances in cancer treatment,prevention,and screening-a report from the American Society of Clinical Oncology显示文摘 | Herbst RS Bajorin DF Bleiberg H | 2006 | J Clin Oncol2006，24，1： | 1 |
| 7 | Clinical Cancer Advances 2007 : Major Research Advances in Cancer Treatment, Prevention, and Screening-A Report From the American Society of clinical oncology显示文摘 | GRALOW J OZOLS RF BAJORIN DF | 2007 | J Clin Oncol2007，26，2： | 1 |
| 8 | Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF显示文摘 | Sharma P Bajorin DF Jungbluth AA | 2008 | J Immunother2008，31，9： | 1 |
| 9 | Advanced bladder ca-ncer:status of first-line chemotherapy and the search for active agents in the second-line setting显示文摘 | Gallagher DJ Milowsky MI Bajorin DF | 2008 | Cancer2008，113，6： | 1 |
| 10 | Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) world 显示文摘 | Roth BJ Bajorin DF | 1995 | J Urol1995，153，： | 1 |
| 11 | Bladder cancer, the limits of surgical excisionwhen/how much?显示文摘 | HERR HW DONAT SM BAJORIN DF | 2001 | Urol Oncol2001，6，： | 1 |
| 12 | Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting 显示文摘 | Gallagher DJ Milowsky MI Bajorin DF | 2008 | Cancer2008，113，6： | 1 |
| 13 | New data, new paradigms for treating prostate cancer patients-VI: Novel hormonal therapy approaches显示文摘 | DREICER R BAJORIN DF MCLEOD DG | 2011 | Urolory2011，78，5： | 1 |
| 14 | Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer:ten-year outcome显示文摘 | Herr HW Bajorin DF Scher HI | 1998 | J Clin Oncol1998，16，4： | 1 |
| 15 | Neoadju vant ch emotherapy and bladder-sparing surgery for invssive bladder cancer:ten-year out come显示文摘 | Herr HW Bajorin DF Scher HI | | 0，，04： | 1 |
| 16 | Neoadjuvant chemotherapy and bladder sparing surgery for invasive bladder cancer:ten year outcome显示文摘 | Herr HW Bajorin DF Scher HI | 1998 | J Clin Oncol1998，16，： | 1 |
| 17 | Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy显示文摘 | Batar A Bajorin DF Milowsky MI | 2011 | Ther Adv Urol2011，3，： | 1 |
| 18 | Toxicology and pharmacokinetics of intravesical gemcitabine: a preclinical study in dogs显示文摘 | COZZI PJ BAJORIN DF TONG W | 1999 | Clin CancerRes1999，5，9： | 1 |
| 19 | Seguential dose-intensive paclitaxel plus ifosfamide and carboplatin plus etoposide with autologous stem cell transplantation for germ cell tumor(GCT) patients 显示文摘 | Kondagunta GV Bacik J Bajorin DF | 2005 | Proc Am Soc Clin Oncnl2005，23，73： | 1 |
| 20 | Clinical Cancer Advances 2005:major research advances in cancer treatment,prevention,and screening--a report from the American Society of Clinical Oncology显示文摘 | Herbst RS Bajorin DF Bleiberg H | 2006 | J Clin Oncol2006，24，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员